BioSpace News Archive

Following up on their landmark 2016 study, researchers at NYU Grossman School of Medicine found that a one-time, single-dose treatment of psilocybin, a compound found in psychedelic mushrooms, combined with psychotherapy appears to be associated with significant improvements in emotional and existential distress in cancer patients.

The article notes the correlation of high levels of circulating inflammatory cytokines, or “cytokine storm,” with severity of illness in patients infected with the Wuhan coronavirus (2019-nCoV).

Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) and (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that the European Patent Office has indicated its intent to grant the Company a patent for its invention titled “Methods and Compositions for Oral Administration of Proteins,

Appili Therapeutics Inc. (TSXV: APLI) (the Company or Appili), a biopharmaceutical company developing anti-infective drug candidates, today announced that Dr. Carl Gelhaus, Senior Program Manager of the Medical Countermeasures Division at MRIGlobal, will present positive interim data on Appili’s ATI-1701 program at the 2020 ASM Biothreats conference.

Special meetings of OpGen and Curetis shareholders are scheduled for March 10, 2020, at 10:00am ET and 1:00pm CET, respectively

The management team of Specialty diagnostics company Precipio, Inc., would like to provide an explanation on the recent Amendment to the S-1 that was filed yesterday, on January 27, 2020.

Assure Holdings Corp., a provider of intraoperative neuromonitoring services, has entered into an agreement with a five-surgeon group based in Western Colorado.

CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, today announced that it is exploring leronlimab as a potential treatment for patients infected with the 2019 Novel Coronavirus (2019-nCoV), a rapidly spreading virus and potential worldwide emergency.

Dentist and Educator Unveils New Category of Restorative Material

Correvio Pharma Corp., announced that it has received two written notifications from The Nasdaq Stock Market LLC notifying the Company that it is not in compliance with the minimum bid price and the minimum market value of listed securities requirements set forth in Nasdaq Listing Rules for continued listing on the Nasdaq Capital Market.